Moderna antibody preliminary temporary workers neglect to select enough minorities, inciting lull Kumar Jeetendra | October 6, 2020 Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enrol enough Black, Latino and Native American participants to ascertain how well the vaccine works in such populations, company executives and vaccine researchers told Reuters. To compensate for the shortfall, Moderna slowed registration of its late-stage trial and educated …
High-dosage favipiravir ‘strong’ against COVID-19, HCQ totally incapable: Study Kumar Jeetendra | October 11, 2020 Research conducted at the KU Leuven Rega Institute in Belgium has found that the antimalarial drug hydroxychloroquine (HCQ) doesn’t limit the multiplication of the novel coronavirus. However, a very high dose of the flu drug favipiravir does have antiviral efficacy, according to their results. The researchers gave the hamsters either hydroxychloroquine or favipiravir for four …
Avenue Therapeutics gets letter from USFDA for intravenous tramadol Kumar Jeetendra | October 12, 2020 Therapeutics Inc has received a complete response letter (CRL) in the US health regulator for its new drug application for intravenous tramadol. The CRL in the US Food and Drug Administration (USFDA) has said that the regulator has decided it cannot approve the application for IV tramadol in its current form, Avenue Therapeutics said in …
Handwashing a compelling device to forestall COVID-19, different ailments: WHO Kumar Jeetendra | October 15, 2020 Ten weeks into the pandemic, handwashing with soap and other public health measures like maintaining physical distance, practising cough etiquette and wearing a mask stay the best defence against coronavirus, the World Health Organisation said Global Handwashing Day is observed on October 15 each year to increase awareness and emphasize the importance of handwashing as …
Britain draws nearer to COVID-19 immunization preliminaries that contaminate volunteers Kumar Jeetendra | October 16, 2020 “Human challenge” trials of possible COVID-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality after a British biotech firm signed a contract with the government to create and provide strains of this virus. Preliminary work for the trials, which aim to accelerate the process of determining the efficacy of a …
US preliminary of AstraZeneca COVID-19 immunization may continue this week: Sources Kumar Jeetendra | October 21, 2020 AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this week following the U.S. Food and Drug Administration completed its review of a severe illness in a study participant, four sources told Reuters. AstraZeneca’s large, late-stage U.S. trial was on hold since Sept. 6, following a participant at …
New Virus rules in Madrid as Spain thought about public crisis Kumar Jeetendra | October 24, 2020 New coronavirus restrictions were to take effect in Madrid on Saturday since the Spanish authorities weighed declaring a national state of emergency to allow curfews to be imposed. Just days after Spain registered more than one million virus instances, the regions — responsible for managing public health — have heaped pressure on the authorities to …
GSK, Sanofi to make 200 million doses accessible for COVID-19 antibody union Kumar Jeetendra | October 28, 2020 French drugmaker Sanofi SA and Britain’s GlaxoSmithKline plan to create 200 million doses of the COVID-19 vaccine candidate accessible to the vaccine allocation program co-led by GAVI and the World Health Organization. The companies said on October 28 they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan …
WHO-drove COVID-19 medication plot copies down on antibodies, steroids and disregards remdesivir Kumar Jeetendra | November 6, 2020 A World Health Organization-led scheme to provide COVID-19 drugs to poor countries is gambling on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated October 30, states the priorities are to secure monoclonal antibodies in a tight market …
Singapore working on making sure about arrangement of COVID-19 vaccines Kumar Jeetendra | November 10, 2020 Singapore will work towards procuring a”portfolio” of all COVID-19 vaccines to appeal to various parts of the populace instead of relying upon a single vaccine,” Health Minister Gan Kim Yong said on November 10. Speaking during a digital media conference by the multi-ministry job force on COVID-19, Gan said that the application of a vaccine …
Researchers translate why COVID-19 spares in kids Kumar Jeetendra | November 14, 2020 Researchers have found an integral aspect that might explain why the book coronavirus predominantly affects adults and older individuals while seeming to spare younger kids, an advance that may lead to the development of new treatment strategies for COVID-19. According to the researchers, including those from the Vanderbilt University Medical Center (VUMC) in the united …
Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its corona vaccine Kumar Jeetendra | December 7, 2020 China’s Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its coronavirus vaccine, the companies said on Monday, as it anticipates efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands provide deals and trials of its experimental COVID-19 vaccine CoronaVac …
